Joenja Tablet, Film Coated
Product Images NDC 71274-170

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Joenja (NDC 71274-170). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pharming Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Joenja 01)

Chemical structure of Leniolisib, showing the molecular arrangement including a pyrimidine ring, trifluoromethoxy group, piperidine moiety, and a phosphate group (H3PO4) complex.*

FDA Label Image

Figure 1 (Joenja 02)

A forest plot chart depicting differences in Log10 transformed SPD and Naive B cell levels for Joenja 70 mg tablets taken twice a day versus placebo. Data is shown separately for age groups 12 to <18 years, >=18 years, and overall, including confidence intervals (95% CI) illustrating favorability towards Joenja or placebo.*

FDA Label Image

Principal Display Panel (70 mg Tablet Bottle Carton)

The packaging label for Joenja (leniolisib) tablets, 70 mg strength, film-coated oral tablets. The label includes the proprietary name "Joenja" with the generic name "leniolisib" in parentheses. The package contains 60 tablets and is labeled Rx Only. The manufacturer is Pharming Healthcare Inc., located in Warren, NJ. The label also provides storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (50 mg Tablet Bottle Carton)

Packaging label for Joenja (leniolisib) tablets 50 mg film-coated oral tablets. The label displays the product name, active ingredient, strength, and the quantity of 60 tablets. Manufactured by Pharming Healthcare Inc., the design includes purple and orange branding elements along with storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (40 mg Tablet Bottle Carton)

Packaging label for Joenja 40 mg tablets (leniolisib), a human prescription oral film-coated tablet. The label indicates it contains 60 tablets and is manufactured for Pharming Healthcare Inc., located in Warren, NJ, USA. The label includes storage instructions, dosage reference, and barcode with NDC 71274-140-60.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.